J.P. Morgan Maintains MakeMyTrip(MMYT.US) With Buy Rating, Raises Target Price to $120
Express News | MakeMyTrip Ltd : JP Morgan Raises Target Price to $120 From $100
Top 3 Consumer Stocks Which Could Rescue Your Portfolio This Quarter
BofA Securities Maintains MakeMyTrip(MMYT.US) With Buy Rating, Maintains Target Price $112
Makemytrip Poised for Growth: Strong Outlook Despite Seasonal Slowdown
Regeneron Pharma, Super Micro Computer And Global Payments Are Among Top 10 Large Cap Losers Last Week (Sept 23-Sept 27): Are The Others In Your Portfolio?
12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session
Is Makemytrip Ltd. (MMYT) the Best Performing Stock in 2024?
Is MakeMyTrip (NASDAQ:MMYT) Using Too Much Debt?
MakeMyTrip Limited (MMYT): This Vacation Stock Is A Good Addition To Your Portfolio Now
Returns On Capital Are Showing Encouraging Signs At MakeMyTrip (NASDAQ:MMYT)
MakeMyTrip (MMYT) Beats Stock Market Upswing: What Investors Need to Know
MakeMyTrip Shareholders Approve All Resolutions
Investors Still Waiting For A Pull Back In MakeMyTrip Limited (NASDAQ:MMYT)
Here's Why MakeMyTrip (MMYT) Fell More Than Broader Market
US stocks are bullish! Multiple medical stocks and public utility stocks rise together due to expectations of interest rate cuts; With frequent bullish news, Tesla surges more than 4% overnight.
The NASDAQ company opened higher with a gap as major bank analysts raised their rating. It rose nearly 3% yesterday and has risen nearly 30% year-to-date.
MakeMyTrip Price Target Raised to $112.00/Share From $100.00 by B of A Securities
MakeMyTrip Is Maintained at Buy by B of A Securities
Demystifying MakeMyTrip: Insights From 4 Analyst Reviews
B of A Securities Maintains Buy on MakeMyTrip, Raises Price Target to $112